These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 29990699)

  • 1. Neutrophils contribute to the pathogenesis of hemorrhagic cystitis induced by ifosfamide.
    Dornelas-Filho AF; Pereira VBM; Wong DVT; Nobre LMS; Melo AT; Silva CMS; Wanderley CWS; Nour ML; Araújo LCNC; Silva RO; Pinto FMM; Bingana RD; Souza MHLP; Alencar NMN; Silva PGB; Alves APNN; Almeida PRC; Cunha FQ; Lima-Júnior RCP
    Int Immunopharmacol; 2018 Sep; 62():96-108. PubMed ID: 29990699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparision of uroprotective activity of reduced glutathione with mesna in ifosfamide induced hemorrhagic cystitis in rats.
    Ali SA; Danda SK; Basha SA; Rasheed A; Ahmed O; Ahmed MM
    Indian J Pharmacol; 2014; 46(1):105-8. PubMed ID: 24550594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Target Inhibition of IL-1 Receptor Prevents Ifosfamide Induced Hemorrhagic Cystitis in Mice.
    Leite CA; Alencar VT; Melo DL; Mota JM; Melo PH; Mourão LT; Wong DV; Magalhães PJ; Santos AA; Brito GA; Lima-Júnior RC; Cunha FQ; Ribeiro RA
    J Urol; 2015 Dec; 194(6):1777-86. PubMed ID: 26220217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of dexamethasone with mesna for the prevention of ifosfamide-induced hemorrhagic cystitis.
    Vieira MM; Brito GA; Belarmino-Filho JN; Macedo FY; Nery EA; Cunha FQ; Ribeiro RA
    Int J Urol; 2003 Nov; 10(11):595-602. PubMed ID: 14633084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A retrospective study of treatment and prophylaxis of ifosfamide-induced hemorrhagic cystitis in pediatric and adolescent and young adult (AYA) patients with solid tumors.
    Saito Y; Kumamoto T; Makino Y; Tamai I; Ogawa C; Terakado H
    Jpn J Clin Oncol; 2016 Sep; 46(9):856-61. PubMed ID: 27380806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effect of ketamine against hemorrhagic cystitis in rats receiving ifosfamide.
    Ozguven AA; Yılmaz O; Taneli F; Ulman C; Vatansever S; Onag A
    Indian J Pharmacol; 2014; 46(2):147-51. PubMed ID: 24741183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclooxygenase-2 expression on ifosfamide-induced hemorrhagic cystitis in rats.
    Macedo FY; Baltazar F; Almeida PR; Távora F; Ferreira FV; Schmitt FC; Brito GA; Ribeiro RA
    J Cancer Res Clin Oncol; 2008 Jan; 134(1):19-27. PubMed ID: 17638016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amifostine and glutathione prevent ifosfamide- and acrolein-induced hemorrhagic cystitis.
    Batista CK; Mota JM; Souza ML; Leitão BT; Souza MH; Brito GA; Cunha FQ; Ribeiro RA
    Cancer Chemother Pharmacol; 2007 Jan; 59(1):71-7. PubMed ID: 16708234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous subcutaneous administration of mesna to prevent ifosfamide-induced hemorrhagic cystitis.
    Markman M; Kennedy A; Webster K; Kulp B; Peterson G; Belinson J
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):97-8. PubMed ID: 8677458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review of Advances in Uroprotective Agents for Cyclophosphamide- and Ifosfamide-induced Hemorrhagic Cystitis.
    Matz EL; Hsieh MH
    Urology; 2017 Feb; 100():16-19. PubMed ID: 27566144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor necrosis factor-alpha and interleukin-1beta mediate the production of nitric oxide involved in the pathogenesis of ifosfamide induced hemorrhagic cystitis in mice.
    Ribeiro RA; Freitas HC; Campos MC; Santos CC; Figueiredo FC; Brito GA; Cunha FQ
    J Urol; 2002 May; 167(5):2229-34. PubMed ID: 11956484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [8] and [10]-Gingerol reduces urothelial damage in ifosfamide-induced hemorrhagic cystitis via JAK/STAT/FOXO signaling pathway via IL-10.
    Ferreira FCS; Clementino M; Rodrigues FAP; Veras HN; Martins DS; Queiroga ML; Lima MA; Silva DO; de Freitas TM; Ribeiro SA; Mota MRL; da Silva JA; Lima AAM; Havt A
    Naunyn Schmiedebergs Arch Pharmacol; 2023 Aug; 396(8):1773-1786. PubMed ID: 36843129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral administration of mesna with ifosfamide.
    Goren MP
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):91-6. PubMed ID: 8677457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological and histopathological study of cyclophosphamide-induced hemorrhagic cystitis - comparison of the effects of dexamethasone and Mesna.
    Morais MM; Belarmino-Filho JN; Brito GA; Ribeiro RA
    Braz J Med Biol Res; 1999 Oct; 32(10):1211-5. PubMed ID: 10510257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of further cyclophosphamide induced hemorrhagic cystitis by hyperbaric oxygen and mesna in guinea pigs.
    Korkmaz A; Oter S; Deveci S; Goksoy C; Bilgic H
    J Urol; 2001 Sep; 166(3):1119-23. PubMed ID: 11490309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility and efficacy of arginine 2-mercaptoethanesulfonate (ARGIMESNA) in the prevention of hemorragic cystitis from ifosfamide (IFO).
    Frustaci S; Foladore S; De Pascale A; Freschi A; Lo Re G; Sorio R; Errante D; Monfardini S
    Ann Oncol; 1992 Apr; 3 Suppl 2():S115-8. PubMed ID: 1622852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the compounds MV8608 and MV8612 obtained from Mandevilla velutina in the model of hemorrhagic cystitis induced by cyclophosphamide in rats.
    Santos AA; Leal PC; Edelweiss MI; Lopes TG; Calixto JB; Morrone FB; Campos MM
    Naunyn Schmiedebergs Arch Pharmacol; 2010 Dec; 382(5-6):399-407. PubMed ID: 20809237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined intravenous and oral mesna in outpatients treated with ifosfamide.
    Goren MP; McKenna LM; Goodman TL
    Cancer Chemother Pharmacol; 1997; 40(5):371-5. PubMed ID: 9272112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-11 attenuates ifosfamide-induced hemorrhagic cystitis.
    Mota JM; Brito GA; Loiola RT; Cunha FQ; Ribeiro Rde A
    Int Braz J Urol; 2007; 33(5):704-10. PubMed ID: 17980069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose ifosfamide with mesna and granulocyte-colony-stimulating factor (recombinant human G-CSF) in patients with unresectable malignant mesothelioma.
    Talbot SM; Rankin C; Taub RN; Balcerzak SP; Bhoopalam N; Chapman RA; Baker LH; Middleman EL; Antman KH
    Cancer; 2003 Jul; 98(2):331-6. PubMed ID: 12872353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.